Tag: Biotech and Pharmaceuticals
-
J&J’s run to record highs hasn’t reached the finish line yet. Here are the key drivers
Jim Cramer agrees with UBS: The rally in Johnson & Johnson shares still has room to run.
-
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
The string of deals builds on the Trump administration’s push to link the nation’s drug prices to cheaper ones abroad.
-
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
-
HHS plans new FDA deputy commissioner roles for technology and drugs, sources say
HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.
-
Most Americans aren’t anti-vaccine. They’re uncertain — and that’s a growing public health challenge
The bigger issue at hand may be that many Americans fall into a large, uncertain middle ground – neither firmly pro-vaccine nor staunchly opposed.
-
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 50%
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
-
Trump wants to split the MMR vaccine. Experts say that’s unlikely — and comes with consequences
Doctors and other experts say that splitting the measles, mumps and rubella shot has no scientific basis and is unlikely to get off the ground.
-
Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
Lilly’s Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk’s Wegovy beyond the U.S. market.
-
Trump signs executive order calling for fewer childhood vaccines, falsely linking shots to autism
The order builds on the Trump administration’s efforts to reshape the childhood shot schedule under HHS Secretary RFK Jr., a longtime vaccine skeptic.
-
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany Investment strategy iran Iran war markets news People per politics return russia said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World world cup World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
